2016 ASCO Annual Meeting - ASCO


Powered by SmugMug Log In
Andrew Gregory Sikora, MD, PhD, MBChB, MRCP, speaks during Integrating Immune Checkpoint Inhibitors and Targeted Agents With Surgery and Radiotherapy for Patients With Head and Neck Cancer

Andrew Gregory Sikora, MD, PhD, MBChB, MRCP, speaks during Integrating Immune Checkpoint Inhibitors and Targeted Agents With Surgery and Radiotherapy for Patients With Head and Neck Cancer

Chicago, IL - 2016 ASCO Annual Meeting - Andrew Gregory Sikora, MD, PhD, MBChB, MRCP, speaks during Integrating Immune Checkpoint Inhibitors and Targeted Agents With Surgery and Radiotherapy for Patients With Head and Neck Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 6, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Max Gersh 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org